Detection of DNA Strand Breaks in HeLa Cells in vitro and in Mouse Sarcoma 180 Cells in vivo Induced by an Alkylating Agent, Carboquone, Using in situ Nick Translation

Oncology ◽  
1990 ◽  
Vol 47 (3) ◽  
pp. 282-286 ◽  
Author(s):  
Yoshihiko Maehara ◽  
Hideaki Anai ◽  
Yoshihisa Sakaguchi ◽  
Tetsuya Kusumoto ◽  
Yasunori Emi ◽  
...  
1994 ◽  
Vol 42 (5) ◽  
pp. 613-619 ◽  
Author(s):  
K Fehsel ◽  
K D Kröncke ◽  
H Kolb ◽  
V Kolb-Bachofen

In this study we used in situ nick-translation to analyze apoptotic events in the thymus and in cultured thymocytes at the level of individual cell nuclei. In vitro nuclear DNA strand breaks were observed 3 hr after exposure of thymocytes to dexamethasone (Dex) in 30% of cells and increased to 78% after 15 hr. In sections of 10-day-old mouse thymus, single cells with DNA strand breaks were dispersed throughout the cortex and to a lesser degree in the medulla. In contrast, a large number of clusters of apoptotic cells were seen in the thymic cortex 3-18 hr after injection of Dex or lipopolysaccharide (LPS). After 48 hr apoptotic cells were no longer detectable. Positive signals correlated with the detection of DNA ladders of multimers of about 180 BP size on agarose gels. Electron microscopy confirmed the presence of apoptotic cell clusters and showed that apoptotic foci were located around capillaries in LPS-injected animals. We conclude that in situ nick translation is a suitable method to detect apoptotic nuclei in cultured cells and on cryostat sections. With this method we could demonstrate that in vivo spontaneous apoptosis occurs in single dispersed thymocytes, also including the medulla, whereas experimentally induced apoptosis affects cell clusters, possibly due to high local concentrations of apoptosis inducers.


1995 ◽  
Vol 58 (2) ◽  
pp. 161-170 ◽  
Author(s):  
Satoshi HASHIMOTO ◽  
Takehiko KOJI ◽  
Jianzho NIU ◽  
Takashi KANEMATSU ◽  
Paul K. NAKANE

1997 ◽  
Vol 45 (7) ◽  
pp. 923-934 ◽  
Author(s):  
Jae A. Collins ◽  
Cynthia A. Schandl ◽  
Kristy K. Young ◽  
Josef Vesely ◽  
Mark C. Willingham

Apoptosis, the terminal morphological and biochemical events of programmed cell death, is characterized by specific changes in cell surface and nuclear morphology. In addition, DNA fragmentation in an internucleosomal pattern is detectable in mass cultures of apoptotic cells. However, DNA fragmentation and nuclear morphological changes may not necessarily be associated events. In this study, we examined OVCAR-3 and KB human carcinoma cells using time-lapse video phase-contrast microscopy to characterize the surface and nuclear morphological features of apoptosis in response to treatment with either taxol or ricin. The surface morphological features of apoptosis were the same in both cell types and with both drugs. Using an in situ nick-translation histochemical assay, these single cells were also examined for DNA strand breaks during apoptosis. Surface morphological changes demonstrated discrete stages of cell rounding, surface blebbing, followed by cessation of movement and the extension of thin surface microspikes, followed much later by surface blistering and cell lysis. Nuclear features examined by DAPI cytochemistry demonstrated apoptotic nuclear condensation very early in this sequence, usually at the time of initial surface blebbing. The nick-translation assay, however, demonstrated DNA strand breaks at a much later time, only after the formation of separated apoptotic bodies or after final cell lysis. This study points out the differences between surface and nuclear morphological changes in apoptosis, and the large temporal separation between nuclear morphological changes and major DNA fragmentation detectable by this in situ technique. This result suggests caution in using in situ nick-translation as a direct correlate of internucleosomal DNA fragmentation in apoptosis.


2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 13005-13005 ◽  
Author(s):  
L. Liu ◽  
A. Bulgar ◽  
J. Donze ◽  
B. J. Adams ◽  
C. P. Theuer ◽  
...  

13005 Background: TRC102 (methoxyamine) reverses resistance to alkylating agents by inhibiting base excision repair (BER; a mechanism of DNA repair), thereby increasing DNA strand breaks and potentiating the anti-tumor activity of alkylating agents without additional toxicity, Based on these data, TRC102 is currently being studied in combination with temozolomide in a phase 1 trial. We hypothesized that inhibition of BER by TRC102 would also increase DNA strand breaks and improve the anti-tumor activity of anti-metabolite chemotherapeutics, including pemetrexed, because these agents also produce AP sites that are recognized and repaired by BER. Methods: Pemetrexed- induced AP sites and BER inhibition was quantified using an apurinic/apyrimidinic (AP) site assay in vitro. Single and double DNA strand breaks were quantified by the Comet assay in vitro and anti-tumor activity was assessed in an in vivo xenograft study of subcutaneously implanted H460 human lung cancer cells. Results: Pemetrexed induced and TRC102 reduced the number of available AP sites in pemetrexed- treated H460 cells (by 60–80%), indicating successful inhibition of BER. TRC102 treatment increased DNA strand breaks in pemetrexed-treated H460 cells (2 fold increase versus treatment with pemetrexed alone). Premetrexed treatment alone and in combination with TRC 102 delayed tumor growth in vivo (tumor growth delay of 4.7 days in the 150 mg/m2 pemetrexed alone group, 5.7 days in the 150 mg/m2 pemetrexed + 2 mg/m2 TRC102 group and 6.9 days in the 150 mg/m2 pemetrexed + 4 mg/m2 TRC102 group); in vivo systemic toxicity was not increased. TRC102 alone had no effect in vitro or in vivo. Conclusions: TRC102 effectively inhibits BER in lung cancer cells treated with pemetrexed. Inhibition of DNA repair by TRC102 results in an increase in DNA strand breaks and improved anti-tumor activity versus treatment with pemetrexed alone. Given its preclinical efficacy and safety profile, study of TRC102 combined with pemetrexed in a phase 1 trial is warranted. No significant financial relationships to disclose.


Author(s):  
Charles R. Long ◽  
John R. Dobrinsky ◽  
Wesley M. Garrett ◽  
Lawrence A. Johnson

2006 ◽  
Vol 26 (5) ◽  
pp. 1839-1849 ◽  
Author(s):  
Arman Nabatiyan ◽  
Dávid Szüts ◽  
Torsten Krude

ABSTRACT Genome stability in eukaryotic cells is maintained through efficient DNA damage repair pathways, which have to access and utilize chromatin as their natural template. Here we investigate the role of chromatin assembly factor 1 (CAF-1) and its interacting protein, PCNA, in the response of quiescent human cells to DNA double-strand breaks (DSBs). The expression of CAF-1 and PCNA is dramatically induced in quiescent cells upon the generation of DSBs by the radiomimetic drug bleocin (a bleomycin compound) or by ionizing radiation. This induction depends on DNA-PK. CAF-1 and PCNA are recruited to damaged chromatin undergoing DNA repair of single- and double-strand DNA breaks by the base excision repair and nonhomologous end-joining pathways, respectively, in the absence of extensive DNA synthesis. CAF-1 prepared from repair-proficient quiescent cells after induction by bleocin mediates nucleosome assembly in vitro. Depletion of CAF-1 by RNA interference in bleocin-treated quiescent cells in vivo results in a significant loss of cell viability and an accumulation of DSBs. These results support a novel and essential role for CAF-1 in the response of quiescent human cells to DSBs, possibly by reassembling chromatin following repair of DNA strand breaks.


Sign in / Sign up

Export Citation Format

Share Document